Hypertension in Non-Type 2 Diabetes in Isfahan, Iran: Incidence and Risk Factors

被引:1
|
作者
Janghorbani, Mohsen [1 ]
Aminorroaya, Ashraf [1 ]
Amini, Masoud [1 ]
机构
[1] Isfahan Univ Med Sci, Isfahan Endocrine & Metab Res Ctr, Esfahan, Iran
关键词
BLOOD-PRESSURE; PREVALENCE; POPULATION; AWARENESS; CHILDREN; MELLITUS; DISEASE; ADOLESCENTS; RETINOPATHY; PREDICTORS;
D O I
10.1155/2017/3132729
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. To estimate the incidence of and risk factors for the development of hypertension (HTN) in people with T1D using routinely collected data. Method. The mean 16-year incidence of HTN was measured among 1,167 (557 men and 610 women) nonhypertensive patients with T1D from Isfahan Endocrine and Metabolism Research Center outpatient clinics, Iran. HTN was defined as a systolic blood pressure (BP) of 140mm Hg or higher and/or a diastolic BP 90mm Hg or higher and/or use of antihypertensive medications. The mean (standard deviation [SD]) age of participants was 20.6 years (10.5 years) with a mean (SD) duration of diabetes of 3.6 years (4.8 years) at registration. Results. The prevalence of HTN at baseline was 9.7% (95% CI: 8.2, 11.5). Among the 1,167 patients free of HTN at registration who attended the clinic at least twice in the period 1992-2016, the incidence of HTN was 9.6 (8.0 women and 11.3 men) per 1000 person-years based on 18,870 person-years of follow-up. Multivariate analyses showed that male gender, older age, higher triglyceride, and higher systolic BP were significantly and independently associated with the development of HTN in this population. Conclusion. These findings will help the identification of those patients with T1D at particular risk of HTN and strongly support the case for vigorous control of BP in patients with T1D.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] Hypertension in type 2 diabetes mellitus in Isfahan, Iran: Incidence and risk factors
    Janghorbani, M
    Amini, M
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2005, 70 (01) : 71 - 80
  • [2] Cataract in type 2 diabetes mellitus in Isfahan, Iran: Incidence and risk factors
    Janghorbani, M
    Amini, M
    OPHTHALMIC EPIDEMIOLOGY, 2004, 11 (05) : 347 - 358
  • [3] Incidence of metabolic syndrome and its risk factors among type 2 diabetes clinic attenders in Isfahan, Iran
    Janghorbani, Mohsen
    Amini, Masoud
    ENDOKRYNOLOGIA POLSKA, 2012, 63 (05) : 372 - 380
  • [4] Peripheral neuropathy in type 2 diabetes mellitus in Isfahan, Iran: prevalence and risk factors
    Janghorbani, M.
    Rezvanian, H.
    Kachooei, A.
    Ghorbani, A.
    Chitsaz, A.
    Izadi, F.
    Amini, M.
    ACTA NEUROLOGICA SCANDINAVICA, 2006, 114 (06): : 384 - 391
  • [5] Incidence of and risk factors for diabetic retinopathy in Isfahan, Iran
    Janghorbani, M
    Amini, M
    Ghanbari, H
    Safaiee, H
    OPHTHALMIC EPIDEMIOLOGY, 2003, 10 (02) : 81 - 95
  • [6] Coronary heart disease in type 2 diabetes mellitus in Isfahan, Iran: prevalence and risk factors
    Janghorbani, M
    Amini, M
    Tavassoli, A
    ACTA CARDIOLOGICA, 2006, 61 (01) : 13 - 20
  • [7] Adherence to Glyburide and Metformin and Associated Factors in Type 2 Diabetes in Isfahan, Iran
    Farsaei, Shall
    Sabzghabaee, Ali Mohammad
    Zargarzadeh, Amir Hooshang
    Amini, Massoud
    IRANIAN JOURNAL OF PHARMACEUTICAL RESEARCH, 2011, 10 (04): : 933 - 939
  • [8] Risk scores in ischaemic heart disease patients with type 2 diabetes, Isfahan, Iran
    Maracy, Mohammad Reza
    Hossein, Sayed Mohsen
    Amini, Massoud
    ACTA CARDIOLOGICA, 2008, 63 (06) : 729 - 734
  • [9] Diabetes risk among first-degree relatives of patients with type 2 diabetes in Isfahan, Iran
    Janghorbani, Mohsen
    Amini, Masoud
    OBESITY AND METABOLISM-MILAN, 2009, 5 (3-4): : 114 - 120
  • [10] Progression from optimal blood glucose and pre-diabetes to type 2 diabetes in a high risk population with or without hypertension in Isfahan, Iran
    Janghorbani, Mohsen
    Amini, Masoud
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2015, 108 (03) : 414 - 422